Anti-VEGFR, PDGFR, and CSF1R tyrosine kinase inhibitor CM082 (X-82) in combination with everolimus for treatment of metastatic renal cell carcinoma: a phase 1 clinical trial
Titel:
Anti-VEGFR, PDGFR, and CSF1R tyrosine kinase inhibitor CM082 (X-82) in combination with everolimus for treatment of metastatic renal cell carcinoma: a phase 1 clinical trial
Auteur:
Yan, Xieqiao Sheng, Xinan Tang, Bixia Chi, Zhihong Cui, Chuanliang Si, Lu Mao, Li Li Lian, Bin Li, Siming Zhou, Li Wang, Xuan Bai, Xue Kong, Yan Dai, Jie Guo, Jun